RxDoctor Payments Data

Amy de la Fuente

Adult Health · Sebring, FLNPI 1811364300

Payments from drug & device makers

$256in general payments, 2019–2025

Across 12 payments — averaging $21.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$91
  • AstraZeneca$43
  • Indivior Inc.$28
  • AbbVie$24
  • Exact Sciences$20
  • Pfizer$20
  • plus $30 from 2 others

What the payments were for

  • Food & beverage$256100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$256 in reported general payments places this provider in the 35th percentile of 2,237 adult health providers in Florida.

See all adult health providers in Florida

Medicare billing

Part B allowed, 2024
$18,348
Medicare patients
42
Services billed
180

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide72$81,924
MounjaroTirzepatide55$76,450
Dupixent PenDupilumab11$48,696
TrulicityDulaglutide31$36,389
Trelegy ElliptaFluticasone/Umeclidin/Vilanter32$23,157
LinzessLinaclotide26$22,945
JardianceEmpagliflozin21$16,220
Tresiba Flextouch U-200Insulin Degludec14$14,019
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl23$6,207
SymbicortBudesonide/Formoterol Fumarate18$4,636
Tresiba Flextouch U-100Insulin Degludec12$4,262
Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine19$2,453
Dexlansoprazole DrDexlansoprazole13$2,187
Alprazolam164$2,114
Albuterol Sulfate HfaAlbuterol Sulfate75$1,937

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$24$22,94526 claims
Boehringer IngelheimJardiance$16$16,22021 claims
AstraZenecaSymbicort$43$4,63618 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 2,237 adult health providers in Florida.

Other adult health in Sebring

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →